Cas:31182-22-6 n,n-di-sec-butylthiourea manufacturer & supplier

Chemical Name:n,n-di-sec-butylthiourea

CAS.NO:31182-22-6

Synonyms:N.N’-Di-(sek.-butyl)-thioharnstoff;N.N’-Di-(dl-sek.-butyl)-thioharnstoff;N,N’-Di-sec-butyl-thioharnstoff;1,3-di-sec.-butylthiourea;N,N’-Di-s-butylthioharnstoff;N,N’-DI-SEC-BUTYLTHIOUREA

Molecular Formula:C₉H₂₀N₂S

Molecular Weight:188.33300

HS Code:2930909090

Physical and Chemical Properties:

Melting point:98-100ºC

Boiling point:255.2ºC at 760mmHg

Density:0.971g/cm3

Index of Refraction:1.491

PSA:56.15000

Exact Mass:188.13500

LogP:2.82930

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N.N’-Di-(sek.-butyl)-thioharnstoff chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,N’-DI-SEC-BUTYLTHIOUREA physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,N’-Di-s-butylthioharnstoff Use and application,N,N’-Di-s-butylthioharnstoff technical grade,usp/ep/jp grade.

Related News: “The Agency also noted that no effect was seen in the two studies that included patients from EU populations, including the most recent study which involved patients who were receiving the maximum and optimal treatment for their Parkinson’s disease,” EMA said. cis-Bicyclo(2.2.2)octan-2,3-dicarbonsaeure-bis-(ethoxycarbonyl)-ester manufacturers Conducted by Innovent in China, the CIBI321A101 trial is a Phase 1a open-label, multi-center study of the safety, tolerability and primary efficacy of IBI321 in patients with advanced solid tumors. Phase 1a of the study will evaluate dosing of IBI321 in a variety of solid tumors (ClinicalTrials.gov, NCT04911894). dimethylthallium(III) tetraphenylborate suppliers The Plexxikon patents are for compounds that reduce cancer cell growth by blocking V600E mutated BRAF. Patents were filed as early as 2005. 5-chloro-2-methyl-1H-quinazolin-4-one vendor & factory.